These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25274570)

  • 1. Construction and evaluation of a chimeric protein made from Fasciola hepatica leucine aminopeptidase and cathepsin L1.
    Hernández-Guzmán K; Sahagún-Ruiz A; Vallecillo AJ; Cruz-Mendoza I; Quiroz-Romero H
    J Helminthol; 2016 Jan; 90(1):7-13. PubMed ID: 25274570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep.
    Ortega-Vargas S; Espitia C; Sahagún-Ruiz A; Parada C; Balderas-Loaeza A; Villa-Mancera A; Quiroz-Romero H
    Vaccine; 2019 May; 37(24):3234-3240. PubMed ID: 31036453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasciola hepatica leucine aminopeptidase, a promising candidate for vaccination against ruminant fasciolosis.
    Acosta D; Cancela M; Piacenza L; Roche L; Carmona C; Tort JF
    Mol Biochem Parasitol; 2008 Mar; 158(1):52-64. PubMed ID: 18178266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of recombinant and native immunogenic forms of Fasciola hepatica proteins for serodiagnosis of sheep fasciolosis.
    Mokhtarian K; Meamar AR; Khoshmirsafa M; Razmjou E; Masoori L; Khanmohammadi M; Akhlaghi L; Falak R
    Parasitol Res; 2018 Jan; 117(1):225-232. PubMed ID: 29199372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a pre-selected epitope of cathepsin-L1 in a highly specific peptide-based immunoassay for the diagnosis of Fasciola hepatica infections in cattle.
    Cornelissen JB; Gaasenbeek CP; Boersma W; Borgsteede FH; van Milligen FJ
    Int J Parasitol; 1999 May; 29(5):685-96. PubMed ID: 10404262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a Peptide-Carrier Vaccine Based on the Highly Immunogenic Fasciola hepatica Leucine Aminopeptidase.
    Salazar C; Tort JF; Carmona C
    Methods Mol Biol; 2020; 2137():191-204. PubMed ID: 32399930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and differential expression of cathepsin L3 alleles from Fasciola hepatica.
    Zawistowska-Deniziak A; Wasyl K; Norbury LJ; Wesołowska A; Bień J; Grodzik M; Wiśniewski M; Bąska P; Wędrychowicz H
    Mol Biochem Parasitol; 2013 Jul; 190(1):27-37. PubMed ID: 23770026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cloning, expression and immunogenicity analysis of cathepsin L-like protease of Fasciola hepatica].
    Li XJ; Wen XB; Ran XH; Li SD; Wang CR; Piao FZ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Jun; 27(3):195-9. PubMed ID: 19852356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
    Garza-Cuartero L; Geurden T; Mahan SM; Hardham JM; Dalton JP; Mulcahy G
    Vaccine; 2018 Feb; 36(7):958-968. PubMed ID: 29373193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucine aminopeptidase is an immunodominant antigen of Fasciola hepatica excretory and secretory products in human infections.
    Marcilla A; De la Rubia JE; Sotillo J; Bernal D; Carmona C; Villavicencio Z; Acosta D; Tort J; Bornay FJ; Esteban JG; Toledo R
    Clin Vaccine Immunol; 2008 Jan; 15(1):95-100. PubMed ID: 18003812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
    Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
    Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing and Developing Serological Test for the Diagnosis of Human Fascioliasis Using a New Recombinant Multi-epitope.
    Aghamolaei S; Mamaghani AJ; Ashrafi K; Kazemi B; Bandehpour M; Rouhani S; Rashidi S; Tabaei SJS
    Acta Parasitol; 2024 Mar; 69(1):1005-1015. PubMed ID: 38498251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasciola hepatica and Fasciola gigantica: cloning and characterisation of 70 kDa heat-shock proteins reveals variation in HSP70 gene expression between parasite species recovered from sheep.
    Smith RE; Spithill TW; Pike RN; Meeusen EN; Piedrafita D
    Exp Parasitol; 2008 Apr; 118(4):536-42. PubMed ID: 18190913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep.
    Piacenza L; Acosta D; Basmadjian I; Dalton JP; Carmona C
    Infect Immun; 1999 Apr; 67(4):1954-61. PubMed ID: 10085042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and expression of polytopic construct of cathepsin-L1, SAP-2 and FhTP16.5 proteins of
    Aghamolaei S; Kazemi B; Bandehpour M; Ranjbar MM; Rouhani S; Javadi Mamaghani A; Tabaei SJS
    J Helminthol; 2020 Mar; 94():e134. PubMed ID: 32127056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of anti-Cathepsin L1: a more reliable method for serodiagnosis of human fasciolosis.
    Mokhtarian K; Akhlaghi L; Mohammadi M; Meamar AR; Razmjou E; Khoshmirsafa M; Falak R
    Trans R Soc Trop Med Hyg; 2016 Sep; 110(9):542-550. PubMed ID: 27794095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins.
    Raina OK; Nagar G; Varghese A; Prajitha G; Alex A; Maharana BR; Joshi P
    Acta Trop; 2011 Jun; 118(3):217-22. PubMed ID: 21376699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.
    Mirzadeh A; Yoosefy A; Kazemirad E; Barati Z; Golkar M; Babaie J; Jafarihaghighi F; Valadkhani Z
    PLoS One; 2018; 13(10):e0203490. PubMed ID: 30281608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development.
    Dalton JP; Robinson MW; Mulcahy G; O'Neill SM; Donnelly S
    Vet Parasitol; 2013 Aug; 195(3-4):272-85. PubMed ID: 23623183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning of a member of the Fasciola hepatica saposin-like protein family.
    Espino AM; Hillyer GV
    J Parasitol; 2003 Jun; 89(3):545-52. PubMed ID: 12880256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.